The global immunotherapy drugs market is anticipated to grow at a CAGR of 9.0% during the forecast period. The increasing clinical trials to develop more immunotherapy drugs is a key factor driving the growth of the market. For instance, in July 2022, Sosei Group Corp., an international biopharmaceutical company and Cancer Research UK, the world’s largest private funder of cancer research signed an agreement to bring Sosei Heptares’ cancer immunotherapy drug candidate into a first-in-human trial. Under the Clinical Trial and Licence Agreement (CTLA), Cancer Research UK’s Centre for Drug Development will sponsor, design and execute a Phase I/IIa clinical trial of HTL00397322, a novel selective EP4 antagonist. 

Get Free Sample link @ https://www.omrglobal.com/request-sample/immunotherapy-drugs-market

Sosei Heptares will be responsible for CTA enabling activities, including GLP toxicology, IMP manufacture1 and other necessary pre-clinical studies in preparation for the opening of the clinical trial. Sosei Heptares holds a license to the results generated under the trial to continue the clinical development and commercialization of HTL0039732. HTL0039732 has been proposed for a range of cancers including microsatellite stable3 colorectal, gastroesophageal, head and neck and castration- resistant prostate cancer. 

In July 2022, Immunocare Holdings plc, a UK-based, commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases including cancer, autoimmune and infectious diseases, announced that its first patient has received new immunotherapy drug for HIV in the clinical trial. These clinical trials are offering an opportunity for the growth of the global immunotherapy drugs market. 

Full report of Immunotherapy Drugs Market available @ https://www.omrglobal.com/industry-reports/immunotherapy-drugs-market

Market Coverage

Segment Covered- 

o             By Type

o             By Therapeutic Application

o             By End-User 

Regions Covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

Competitive Landscape- F. Hoffman L-Roche Ltd., Pfizer Inc., and Merck & Co., Inc., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Immunotherapy Drugs Market Report by Segment

By Type

Monoclonal Antibodies
Checkpoint Inhibitors
Interferons & Interleukins
Others

By Therapeutic Application 

Cancer
Infectious Diseases
Autoimmune & Inflammatory
Others

By End-User 

Hospitals
Clinics
Others 

Global Immunotherapy Drugs Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Italy
Spain
France
Rest of Europe 

Asia-Pacific

China
India
Japan
South Korea
Rest of Asia-Pacific 

Rest of the World

Latin America 
Middle East & Africa




Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immunotherapy-drugs-market





Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.